Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01801059 · ClinicalTrials.gov registry record · NA

Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer

A NA study of Colon Cancer and Rectal Cancer, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
284
Enrollment target
1
Study location

NCT01801059 is a NA study of Colon Cancer and Rectal Cancer that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 284 participants, below the 4,453-participant average among 97 other Colon Cancer trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01801059, a NA study of Colon Cancer and Rectal Cancer, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
284 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and number of completed screening tests for colorectal cancer.

Interventions

  • OTHER questionnaire administration
  • OTHER educational intervention

Study Locations (1)

Ohio

  • Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 284 participants
Start Date 2007-09
Est. Completion 2010-12
Phase NA

What the Registry Record Tells You About NCT01801059

The ClinicalTrials.gov registry entry for NCT01801059 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 284 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,453-participant average among 97 other Colon Cancer trials with a reported enrollment target (94% lower). The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Colon Cancer appearing as the primary indexed condition, and to 2 interventions - of which questionnaire administration is the first listed.

NCT01801059 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01801059 about?

NCT01801059 is a clinical study titled "Patient Activation Intervention in Improving Screening Rates for Colorectal Cancer". This randomized clinical trial focused on activating the patient to ask their health care provider for a colorectal cancer screening test to improve screening rates for colorectal cancer. The patient activation intervention may increase information seeking, number of screening tests ordered and numb...

What is the current status of trial NCT01801059?

This trial is currently completed. It is a NA study. The enrollment target is 284 participants. The study started on 2007-09. Estimated completion is 2010-12.

What conditions does trial NCT01801059 study?

This clinical trial studies the following conditions: Colon Cancer, Rectal Cancer.

What interventions are being tested in trial NCT01801059?

The interventions under investigation include: questionnaire administration (OTHER), educational intervention (OTHER).

Who is sponsoring clinical trial NCT01801059?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01801059 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colon Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.